This program will discuss Type 1 Diabetes.  This lecture reviews epidemiology of diabetes, with focus on type 1 diabetes mellitus (T1D) as well as the care of patients with T1D in pregnancy. The first half of the talk will focus on global epidemiology and highlight the prevalence of T1D in adults. The presenter will discuss why identification of T1D is important and how to prevent progression through the stages. The second half of the talk will focus on pregnancy including the targets for care during pregnancy and the impacts of glucose control in range.

Diabetes prevalence is growing globally. Management of glycemia during pregnancy is complicating and dynamic. Glucose targets are as close to normal as possible while minimizing hypoglycemia. Many women become pregnant are already using automated insulin delivery systems that are not FDA approved for use in pregnancy given the lack of pregnancy-specific glucose targets. Counseling women on off-label use of automated insulin delivery systems in pregnancy is necessary, and many times, the automated activity needs to be turned off to meet glycemic targets. Continuous glucose monitoring has shown many benefits for mother and neonate.

Link to transcript

[Link to transcript](https://podcast.osu.edu/osumednet21/wp-content/uploads/sites/27/2026/04/Type1Diabetes_transcript.pdf)

This program will discuss Recurrent UTIs. This program covers current recommendations for evaluation and treatment of recurrent urinary tract infections in women.

Link to transcript

[Link to transcript](https://podcast.osu.edu/osumednet21/wp-content/uploads/sites/27/2026/03/RecurrentUTIs_transcript.pdf)

This program will discuss Pre-malignancies in Hematology. This presentation reviews the spectrum of premalignant hematologic disorders including clonal hematopoiesis, B cell disorders, and plasma cell disorders. First, the presentation will review clonal hematopoiesis of indeterminate potential and clonal cytopenia of undetermined significance. The second part of the talk will go over monoclonal B lymphocytosis. The last portion will cover monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). Learners will review diagnostic criteria, risk stratification models, and clinical monitoring strategies for these conditions. The session will emphasize practical approaches to evaluation, risk assessment, and management decisions in patients with hematologic malignancy precursor conditions.

Link to transcript

[Link to transcript](https://podcast.osu.edu/osumednet21/wp-content/uploads/sites/27/2026/03/Pre-malignanciesinHematology_transcript.pdf)

This program will discuss Pelvic Pain in Women. This presentation covers pelvic pain in women—a complex clinical picture often encompassing multiple organ systems. The lecture will first review definitions and epidemiology before discussing the possible etiologies of pelvic pain. The presenter will use cases to highlight the various diagnoses. It will then dive into the diagnostic workup and treatment for suspected etiologies.

Link to transcript

[Link to transcript](https://podcast.osu.edu/osumednet21/wp-content/uploads/sites/27/2026/03/PelvicPaininWomen_transcript.pdf)

This program will discuss Obstructive Sleep Apnea.  Obstructive Sleep Apnea (OSA) is a heterogeneous condition, sometimes presenting a diagnostic challenge as simple rules are unable to account for the variability seen between patients. This presentation covers the differences between OSA endotypes, phenotypes, risk factors, and diagnostic strategies in a manner meant to update providers for 2026.

Link to transcript

[Link to transcript](https://podcast.osu.edu/osumednet21/wp-content/uploads/sites/27/2026/03/ObstructiveSleepApnea_transcript.pdf)

This program is a review of Medical Errors including causes, pitfalls, and how to improve our system. First the presenter will go through the terminology and epidemiology of medical errors. The presentation will also include a case example and practical steps to identify and reduce medical errors.

Link to transcript

[Link to transcript](https://podcast.osu.edu/osumednet21/wp-content/uploads/sites/27/2026/02/MedicalErrors_transcript.pdf)

This program will discuss Antibiotic and Other Drug Allergies. As drug allergies are a common presenting concern for patients, learners should expect to gain a better ability to differentiate different types of drug allergies, both through clinical features as well as optimal use of allergy testing strategies. They should also be able to feel confident assessing patients with penicillin allergies, as optimal evaluation of these potential allergies can reduce the unnecessary use of alternative antibiotics when penicillin is optimal.

Viewers will learn how to apply principles of drug allergy history taking and testing to specific antibiotic classes with a special focus on cross-reactivity between beta-lactams such as penicillin and cephalosporins. Patient-specific factors including likely need for antibiotics in settings such as surgery and pregnancy will be discussed.

Link to transcript

[Link to transcript](https://podcast.osu.edu/osumednet21/wp-content/uploads/sites/27/2025/11/FoodAllergy_transcript.pdf)

This program will discuss Minimally Invasive Interventional Pain Management.  This program will provide a comprehensive summary on common minimally invasive interventional pain management treatment options: including injection therapy, radiofrequency ablation, peripheral nerve stimulation, spinal cord stimulation, and intrathecal neuromodulation. Discussion for appropriate patients for referral to interventional pain management as well as contraindications for procedures.

Link to transcript

This webcast will discuss Seizures and Spells. Learners should expect to gain an understanding of the clinical approach to seizures and spells, including distinguishing between true epileptic events and conditions that can mimic seizures. The presentation will cover practical evaluation strategies, diagnostic criteria, and clinical cases to illustrate these principles.

Link to transcript

This program will discuss Medications for Obesity. Learners will be able to compare and contrast different pharmacotherapy options for weight management and clinical factors to consider when selecting an appropriate therapy for patients. Learners will be able to navigate the barriers to access for weight management pharmacotherapy and familiarize themselves with how to initiate and titrate pharmacotherapy for weight management.

Link to transcript